Drugs Containing Excipient (Inactive Ingredient) POVIDONE K30

Branded drugs containing POVIDONE K30 excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Genentech Inc	VALCYTE	valganciclovir	0004-0038	POVIDONE K30
Genentech Inc	INVIRASE	saquinavir mesylate	0004-0244	POVIDONE K30
Genentech Inc	TAMIFLU	oseltamivir phosphate	0004-0802	POVIDONE K30
Merck Sharp & Dohme LLC	JANUMET	sitagliptin and metformin hydrochloride	0006-0078	POVIDONE K30
Merck Sharp & Dohme LLC	JANUMET	sitagliptin and metformin hydrochloride	0006-0575	POVIDONE K30
Pfizer Laboratories Div Pfizer Inc	ARTHROTEC	diclofenac sodium and misoprostol	0025-1411	POVIDONE K30
Novartis Pharmaceuticals Corporation	MYFORTIC	mycophenolic acid	0078-0386	POVIDONE K30

Generic drugs containing POVIDONE K30 excipient

Company	Ingredient	NDC	Excipient
Genentech Inc	valganciclovir	0004-0038	POVIDONE K30
Genentech Inc	saquinavir mesylate	0004-0244	POVIDONE K30
Genentech Inc	oseltamivir phosphate	0004-0802	POVIDONE K30
Merck Sharp & Dohme LLC	sitagliptin and metformin hydrochloride	0006-0078	POVIDONE K30
Merck Sharp & Dohme LLC	sitagliptin and metformin hydrochloride	0006-0575	POVIDONE K30
Pfizer Laboratories Div Pfizer Inc	diclofenac sodium and misoprostol	0025-1411	POVIDONE K30
Hikma Pharmaceuticals USA Inc	mefloquine hydrochloride	0054-0025	POVIDONE K30

Market Dynamics and Financial Trajectory for POVIDONE K30

Last updated: February 20, 2026

What Is POVIDONE K30?

POVIDONE K30, also known as polyvinylpyrrolidone (PVP) K30, is a synthetic polymer used as an excipient in pharmaceuticals. It functions as a binder, film former, dispersant, and stabilizer for drugs and formulations. Its solubility and compatibility make it suitable across a broad spectrum of oral, topical, and parenteral applications.

Market Size and Growth Trends

Global Market Size (2022)

The POVIDONE K30 market was valued approximately at USD 150 million in 2022. Key regional markets include Asia Pacific, North America, and Europe.

Region	Market Share (2022)	Growth Rate (CAGR 2023-2028)
Asia Pacific	45%	6.2%
North America	25%	4.3%
Europe	20%	3.8%
Rest of World	10%	5.5%

Growth Drivers

• Expansion of generic and branded drug markets increases demand for excipients like POVIDONE K30.
• Growth in biologics and biosimilars requires stabilizers and dispersants.
• Increasing R&D investments in pharmaceuticals seeking cost-effective excipients.
• Rising prevalence of chronic diseases (e.g., cardiovascular, infectious diseases) boosts pharmaceutical production.

Market Forecast (2023-2028)

Projected CAGR of 4.5% results in an estimated USD 200 million market by 2028, driven primarily by Asia Pacific and emerging markets.

Competitive Landscape

Leading manufacturers include:

• Ashland Global Holdings Inc.
• BASF SE
• FMC Corporation
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
• Shandong Qilu Pharmaceutical Co., Ltd.

These firms focus on quality standards (USP, EP) and product consistency, influencing pricing and supply stability.

Pricing Trends

Average price per kilogram (2022): USD 20-25, depending on purity standards and contract volume.

Prices tend to decrease marginally due to economies of scale and intensified regional competition.

Regulatory Environment Impact

• US Pharmacopeia (USP) and European Pharmacopoeia (EP) specifications define quality requirements.
• Increasing regulations for pharmaceutical excipients emphasize quality assurance, affecting manufacturing costs.
• Registration in emerging markets requires adherence to local standards, expanding regulatory complexity.

Challenges Impacting Market Growth

• Environmental and safety concerns related to manufacturing processes.
• Limited manufacturing capacity in certain regions constrains supply.
• Competition from alternative excipients with similar functional properties (e.g., hydroxypropyl cellulose).

Financial Trajectory

Revenue Streams

• Contract manufacturing for pharmaceutical companies.
• Custom synthesis for specialized applications.
• Proprietary formulations incorporating POVIDONE K30.

Cost Structures

Expenses include raw materials (vinyl pyrrolidone), manufacturing, quality control, and regulatory compliance. Raw material costs fluctuate with upstream polymer and petrochemical markets, influencing overall pricing.

Profit Margins

Gross margins typically range from 25-35% based on scale, market segment, and product purity.

Investment Trends

Firms investing in capacity expansion and R&D to develop modified grades (e.g., cross-linked POVIDONE) for advanced applications.

Key Market Trends and Innovations

• Development of high-purity, low-volatile grades supports parenteral and biotech applications.
• Use of environmentally friendly manufacturing processes gains regulatory approval and market favor.
• Collaboration between excipient suppliers and pharmaceutical innovators accelerates new product approvals.

Conclusion

The POVIDONE K30 market exhibits steady growth driven by increased pharmaceutical production, especially in Asia Pacific. While competitive pressures and regulatory complexities remain, supply stability and innovation in grades support positive financial trajectories for key players.

Key Takeaways

• The global POVIDONE K30 market was valued at USD 150 million in 2022, with a forecasted CAGR of 4.5% to 2028.
• Asia Pacific dominates regional demand due to expanding pharmaceutical manufacturing capacity.
• Pricing remains stable but is influenced by raw material costs and regional competition.
• Regulatory standards drive product quality improvements and manufacturing costs.
• Market growth depends on innovation in grades and manufacturing practices.

FAQs

1. What are the primary applications of POVIDONE K30 in pharmaceuticals?
2. How do regional regulations impact supply chain strategies for POVIDONE K30 manufacturers?
3. What alternative excipients compete with POVIDONE K30 in new formulations?
4. How significant are raw material price fluctuations for profit margins?
5. What innovations are expected to shape the future of POVIDONE K30 in the pharmaceutical industry?

---

References

[1] MarketWatch. (2023). Polymer excipients market size.
[2] GlobalData. (2023). Pharmaceutical excipients industry report.
[3] U.S. Pharmacopeia. (2022). USP monograph for Povidone.
[4] BASF SE. (2022). Product data sheets for pharmaceutical polymers.
[5] Fitch Solutions. (2023). Regulatory impacts on excipient manufacturing.